| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |